Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gefitinib for EGFR Mutant Lung Cancers: Searching for a Weapon of Mass Destruction

Gefitinib for EGFR Mutant Lung Cancers: Searching for a Weapon of Mass Destruction. Journal of Clinical Oncology. 2006; 21(24):3319-3321.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.